Cargando…

CFH-CFHR1 hybrid genes in two cases of atypical hemolytic uremic syndrome

Atypical hemolytic uremic syndrome (aHUS) is a rare complement-mediated disease that manifests as the triad of thrombotic microangiopathy. We identified two aHUS patients with neither anti-complement factor H (CFH) antibodies nor causative variants of seven aHUS-related genes (CFH, CFI, CFB, C3, MCP...

Descripción completa

Detalles Bibliográficos
Autores principales:	Sugawara, Yuka, Kato, Hideki, Nagasaki, Masao, Yoshida, Yoko, Fujisawa, Madoka, Minegishi, Naoko, Yamamoto, Masayuki, Nangaku, Masaomi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Nature Singapore 2023
Materias:	Brief Communication
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10208952/ https://www.ncbi.nlm.nih.gov/pubmed/36755127 http://dx.doi.org/10.1038/s10038-023-01129-1

Ejemplares similares

Pathogenesis of Atypical Hemolytic Uremic Syndrome
por: Yoshida, Yoko, et al.
Publicado: (2019)

Novel CFHR2-CFHR1 Hybrid in C3 Glomerulopathy Identified by Genomic Structural Variation Analysis
por: Sugawara, Yuka, et al.
Publicado: (2019)

Profiles of Coagulation and Fibrinolysis Activation-Associated Molecular Markers of Atypical Hemolytic Uremic Syndrome in the Acute Phase
por: Sakurai, Satoko, et al.
Publicado: (2020)

CFH and CFHR structural variants in atypical Hemolytic Uremic Syndrome: Prevalence, genomic characterization and impact on outcome
por: Piras, Rossella, et al.
Publicado: (2023)

Clinical characteristics and genetic backgrounds of Japanese patients with atypical hemolytic uremic syndrome
por: Fujisawa, Madoka, et al.
Publicado: (2018)

Correction to: Clinical characteristics and genetic backgrounds of Japanese patients with atypical hemolytic uremic syndrome
por: Fujisawa, Madoka, et al.
Publicado: (2019)

Atypical HUS Associated with CFH/CFHR-1 Hybrid Gene
por: Negi, Sharon, et al.
Publicado: (2020)

Deletion of Complement Factor H–Related Genes CFHR1 and CFHR3 Is Associated with Atypical Hemolytic Uremic Syndrome
por: Zipfel, Peter F, et al.
Publicado: (2007)

Atypical hemolytic uremic syndrome: Unique clinical presentation linked to rare CFHR5 mutation
por: Menotti, Sofia, et al.
Publicado: (2021)

Association among Complement Factor H Autoantibodies, Deletions of CFHR, and the Risk of Atypical Hemolytic Uremic Syndrome
por: Jiang, Hong, et al.
Publicado: (2016)

A case of malignant hypertension as a presentation of atypical hemolytic uremic syndrome
por: Omiya, Chiaki, et al.
Publicado: (2023)

Deleterious Impact of a Novel CFH Splice Site Variant in Atypical Hemolytic Uremic Syndrome
por: Schönauer, Ria, et al.
Publicado: (2019)

Associations of CFH Polymorphisms and CFHR1-CFHR3 Deletion with Blood Pressure and Hypertension in Chinese Population
por: Gan, Wei, et al.
Publicado: (2012)

Atypical Hemolytic Uremic Syndrome With the p.Ile1157Thr C3 Mutation Successfully Treated With Plasma Exchange and Eculizumab: A Case Report
por: Saito, Daiki, et al.
Publicado: (2019)

Atypical haemolytic uremic syndrome with refractory multiorgan involvement and heterozygous CFHR1/CFHR3 gene deletion
por: Diep, Jason, et al.
Publicado: (2023)

Acute Progression of Adult-Onset Atypical Hemolytic-Uremic Syndrome due to CFH Mutation: A Case Report
por: Posnik, Bartlomiej, et al.
Publicado: (2013)

Analysis of Linear Antibody Epitopes on Factor H and CFHR1 Using Sera of Patients with Autoimmune Atypical Hemolytic Uremic Syndrome
por: Trojnár, Eszter, et al.
Publicado: (2017)

Plasma resistant atypical hemolytic uremic syndrome associated with a CFH mutation treated with eculizumab: a case report
por: Sevinc, Mustafa, et al.
Publicado: (2015)

High Complement Factor H-Related (FHR)-3 Levels Are Associated With the Atypical Hemolytic-Uremic Syndrome-Risk Allele CFHR3*B
por: Pouw, Richard B., et al.
Publicado: (2018)

Antibody recognition of complement factor H reveals a flexible loop involved in atypical hemolytic uremic syndrome pathogenesis
por: Yokoo, Takanori, et al.
Publicado: (2022)

Safety and effectiveness of eculizumab for adult patients with atypical hemolytic–uremic syndrome in Japan: interim analysis of post-marketing surveillance
por: Kato, Hideki, et al.
Publicado: (2018)

Safety and effectiveness of eculizumab for pediatric patients with atypical hemolytic–uremic syndrome in Japan: interim analysis of post-marketing surveillance
por: Ito, Shuichi, et al.
Publicado: (2018)

Atypical hemolytic uremic syndrome
por: Loirat, Chantal, et al.
Publicado: (2011)

Atypical Hemolytic Uremic Syndrome
por: Kavanagh, David, et al.
Publicado: (2013)

Common haplotypes at the CFH locus and low-frequency variants in CFHR2 and CFHR5 associate with systemic FHR concentrations and age-related macular degeneration
por: Lorés-Motta, Laura, et al.
Publicado: (2021)

Corrigendum: High Complement Factor H-Related (FHR)-3 Levels Are Associated With the Atypical Hemolytic-Uremic Syndrome-Risk Allele CFHR3(*)B
por: Pouw, Richard B., et al.
Publicado: (2020)

Effective immunosuppressive management with belatacept and eculizumab in post-transplant aHUS due to a homozygous deletion of CFHR1/CFHR3 and the presence of CFH antibodies
por: Münch, Johannes, et al.
Publicado: (2017)

Genetic influences on plasma CFH and CFHR1 concentrations and their role in susceptibility to age-related macular degeneration
por: Ansari, Morad, et al.
Publicado: (2013)

CFH and CFHR Copy Number Variations in C3 Glomerulopathy and Immune Complex-Mediated Membranoproliferative Glomerulonephritis
por: Piras, Rossella, et al.
Publicado: (2021)

The genetics of atypical hemolytic uremic syndrome
por: Feitz, Wouter J. C., et al.
Publicado: (2018)

Familial Atypical Hemolytic Uremic Syndrome with Positive p.S1191L (c.3572C>T) Mutation on The CFH Gene: a Single-center Experience
por: Ersoy Dursun, F, et al.
Publicado: (2021)

Clinical features of children with anti-CFH autoantibody-associated hemolytic uremic syndrome: a report of 8 cases
por: Li, Qian, et al.
Publicado: (2022)

How atypical can Atypical Hemolytic Uremic Syndrome be?
por: Sajan, Thomas, et al.
Publicado: (2014)

Postoperative Atypical Hemolytic Uremic Syndrome Associated with Complement C3 Mutation
por: Matsukuma, Eiji, et al.
Publicado: (2014)

Pregnancy-Associated Atypical Hemolytic-Uremic Syndrome
por: Saad, Antonio F., et al.
Publicado: (2016)

Complement and the atypical hemolytic uremic syndrome in children
por: Loirat, Chantal, et al.
Publicado: (2008)

Pediatric Atypical Hemolytic Uremic Syndrome Advances
por: Raina, Rupesh, et al.
Publicado: (2021)

Assesment, Treatment and Prevention of Atypical Hemolytic Uremic Syndrome
por: Nickavar, Azar, et al.
Publicado: (2013)

Critical appraisal of eculizumab for atypical hemolytic uremic syndrome
por: Palma, Lilian M Pereira, et al.
Publicado: (2016)

Atypical hemolytic uremic syndrome and eculizumab therapy in children
por: Kim, Seong Heon, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_pvs7l0bbgnenmfi5oa596h6p8e